Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-25 @ 9:10 PM
Study NCT ID:
NCT03517956
Status:
COMPLETED
Last Update Posted:
2022-07-14
First Post:
2018-05-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid Tumors
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-25
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-01
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-03
First Submit QC Date:
None
Study First Post Date:
2018-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-13
Last Update Post Date:
2022-07-14
Last Update Post Date Type:
ACTUAL